The events which could lift Indivior by 95%
Stockbroker Numis believes that shares in specialty pharmaceutical business Indivior (INDV) could surge by up to 95% over the next year thanks to three potential catalysts.
Since its spin-off from Reckitt Benckiser ...
11 May 2017
